LY-310762 is a drug which acts as a potent and selective antagonist for the 5-HT1D serotonin receptor with reasonable selectivity over the closely related 5-HT1B subtype.
List of articles in "Drug" category - Page 60
1-(2-Diphenyl)piperazine
1-(2-Diphenyl)piperazine also known as RA-7 is a drug which acts as a potent and selective agonist at the 5HT7 serotonin receptor. It was discovered as an active metabolite of the […]
LP-211
LP-211 is a drug which acts as a potent and selective agonist at the 5HT7 serotonin receptor with better brain penetration than older 5-HT7 agonists in the same series and […]
E-55888
E-55888 is a drug developed by Esteve which acts as a potent and selective full agonist at the 5HT7 serotonin receptor and is used for investigating the role of 5-HT7 […]
GR-113808
GR-113808 is a drug which acts as a potent and selective 5-HT4 serotonin receptor antagonist.
SB-258719
SB-258719 is a drug developed by GlaxoSmithKline which acts as a selective 5-HT7 receptor partial inverse agonist and was the first such ligand identified for 5-HT7. Its use in research […]
LP-44
LP-44 is a drug which acts as a potent and selective agonist at the 5HT7 serotonin receptor. While LP-44 is less selective than the related compound LP-12 it has been […]
LP-12
LP-12 is a drug which acts as a potent agonist at the 5HT7 serotonin receptor with very high selectivity over other tested receptor subtypes such as the serotonin 5-HT1A and […]
Hydrocortamate
Hydrocortamate (Magnacort Ulcortis) is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties. It is used topically to treat inflammation due to corticosteroid-responsive dermatoses.
Girentuximab
Girentuximab (trade name Rencarex) is a chimeric monoclonal antibody designed for the treatment of renal cell carcinoma.Girentuximab was developed by Wilex AG.